Company / Free Cash Flow per Share
Biogen Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$14.15
FY2025
5-year range
$7.51 / $19.41
FY2021-FY2025
Trend
-25.1%
vs FY2024
Sector context
#6 of 190
Health Care
What the data says
Among 190 Health Care companies, Biogen is in the top 3% for free cash flow per share. Free Cash Flow per Share has fluctuated over the past 10 years, ranging from $7.51 in FY2022 to $31.04 in FY2019.
Based on SEC 10-K filings.
14.15 in FY2025 with a 5-year CAGR of -6.0%. Top quartile in the Health Care sector.
Improved from $8.64 to $14.15 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +23.5%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
+325.7% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 25.1% year-over-year.
- Ranks #6 out of 190 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2019.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.15 | -25.1% |
| FY2024 | $18.90 | +118.7% |
| FY2023 | $8.64 | +15.1% |
| FY2022 | $7.51 | -61.3% |
| FY2021 | $19.41 | +0.6% |
| FY2020 | $19.30 | -37.8% |
| FY2019 | $31.04 | +23.7% |
| FY2018 | $25.09 | +47.1% |
| FY2017 | $17.06 | -6.1% |
| FY2016 | $18.17 | +30.1% |
As of FY2025 · SEC 10-K · Updated Mar 3, 2026